-
Apple's Tim Cook to step down as CEO in September
-
West Ham's draw at Palace relegates Wolves, piles pressure on Spurs
-
Canadian tourist killed in Mexico archaeological site shooting
-
Wolves relegated from Premier League
-
Oil jumps on Hormuz tensions, stocks mostly retreat
-
Colombian environmental activist honored amid threats and exile
-
Gun battle traps more than 200 tourists at Rio viewpoint
-
Alcaraz may skip French Open rather than rush injury comeback
-
Top US court to hear case of Catholic schools excluded from state funding
-
Trump Fed chair pick to vow interest rate independence at key hearing
-
EU to host Taliban officials for talks on deporting Afghans
-
Blue Origin probing rocket's failure to deliver satellite
-
Pope blasts 'exploitation' as he wraps up tour of Angola
-
Wembanyama 'changing the game as we speak', says Nowitzki
-
Singer D4vd charged with murder after teen's body found in Tesla
-
Swiss football club turn down Kanye West concert approach
-
Leicester fairytale turns sour as relegation to third tier looms
-
Pope Leo blasts 'exploitation' as he wrap up tour of resource-rich Angola
-
Varma ton revives Mumbai's IPL hopes with win over Gujarat
-
Formula One makes rule changes after drivers' criticism
-
Singer D4vd charged with murder over teen's body found in Tesla
-
UK PM denies misleading MPs, says officials hid Mandelson info
-
Tit-for-tat blockades once again cripple traffic in Hormuz
-
Cafu says 2026 World Cup is perfect time for Brazil to win again
-
Erdogan vows new measures after deadly Turkey school shootings
-
Rose to take charge at Bournemouth after Iraola exit
-
Olympic status a massive 'boost' for squash says European champion Crouin
-
Kenyan double-double as Korir, Lokedi defend Boston Marathon crowns
-
Whale stranded on German coast swims off, gets stuck again
-
Iran pulling Hormuz 'lever' to maximum in US standoff
-
Argentine film and theater great Luis Brandoni dies at 86
-
French Open sensation Boisson returns to action after 'most difficult' spell
-
Desmond Morris: from 'Naked Ape' to watching 'Big Brother'
-
Rosenior says Chelsea owners supportive despite slump
-
Oil jumps on Hormuz tensions, stocks retreat
-
Romania legend Hagi eyes 'winning every game' on return as coach
-
Rana stars as Bangladesh down New Zealand to level ODI series at 1-1
-
Real Madrid coach Arbeloa launches stout defence of Mbappe
-
Pope Leo blasts 'exploitation' on visit to resource-rich Angola
-
Amy Winehouse's father loses suit against friends selling her clothes
-
Japan issues warning after 7.7-magnitude quake hits north
-
UniCredit woos Commerzbank shareholders in takeover battle
-
European stocks slide as oil jumps on Hormuz tensions
-
Amy Winehouse's dad loses suit against friends for selling clothes
-
Slovenian liberal Golob fails to form government
-
Elon Musk summoned over French X deepfake probe but presence unclear
-
Tsunami warning as major quake hits northern Japan, shakes Tokyo
-
Rana takes 5-32 as Bangladesh bowl out New Zealand for 198
-
Anthropic says will put AI risks 'on the table' with Mythos model
-
Iran says no plan for US peace talks
TailorMed CEO Srulik Dvorsky to Lead Panel Session on the Impact of Technology on Specialty Pharmacy Affordability Programs at NASP 2025 Conference
Discussion Will Explore How Emerging Innovations Can Lead to Improved Clinical and Financial Outcomes
NEW YORK, NY / ACCESS Newswire / September 3, 2025 / TailorMed, a leading healthcare technology company, announced that co-founder and chief executive officer Srulik Dvorsky will moderate a panel session on patient affordability initiatives during the National Association of Specialty Pharmacy (NASP) 2025 Annual Meeting & Expo at the Gaylord Resort in Denver, Colorado. The conference takes place September 14-17, 2025. Dvorsky's session, "Leveraging Technology to Scale Affordability Programs in Specialty Pharmacy," will take place on September 14 at 10:10 a.m. MT.
During the session, Dvorsky will be joined by leaders from CenterWell, Prime Therapeutics, and Alivia Health. The panelists will examine how technology is improving access to financial assistance for specialty treatments, resulting in better patient outcomes, operational efficiency, and pharmacy performance.
"Despite the many financial assistance programs available, finding and enrolling patients in these resources is often manual and time-consuming, leading to treatment delays and abandonment," said Dvorsky. "This panel session will educate attendees on how pharmacies can streamline and automate affordability workflows, improving adherence, elevating care quality, and increasing revenue."
TailorMed's expansive network brings together leading pharmacies, providers, life science companies, and other stakeholders to broaden access to financial resources. Since its inception, the company has secured more than $5 billion in financial assistance for patients.
TailorMed representatives will be available throughout the conference at booth #426 for discussions and demonstrations of their affordability solutions.
To learn more about TailorMed, please visit https://tailormed.co/.
About TailorMed
TailorMed is a comprehensive, end-to-end platform designed to eliminate barriers along the entire medication journey, from affordability to access and adherence. TailorMed's innovations in healthcare are transforming how stakeholders-patients, providers, pharmacies, life sciences, and payers-work together to ensure that every patient, across all medical conditions, can receive the treatment they need without delay. TailorMed's enterprise solution manages the full lifecycle of patient support programs, reducing the cost of care and driving better outcomes. Thanks to its partnerships with life sciences, TailorMed creates unparalleled automation through direct integration with manufacturer assistance programs. With the nation's largest Affordability Network, deployed across more than 800 hospitals, 1,300 clinics, and 1,400 pharmacies, TailorMed powers organizations to create a seamless patient experience. Learn more at tailormed.co.
![]()
Contact:
Jennifer Martin
[email protected]
PR Contact:
Glenn Goldberg
Parallel Communications Group
+1 516 776-3282
LinkedIn
𝕏: @Parallel_PR
[email protected]
SOURCE: TailorMed
View the original press release on ACCESS Newswire
P.Stevenson--AMWN